Different Modalities of Exercise Training in COPD With Chronic Respiratory Failure (CRF)
Launched by ISTITUTI CLINICI SCIENTIFICI MAUGERI SPA · Dec 16, 2019
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Advanced (Chronic Obstructive Pulmonary Disease) COPD is a condition with a negative prognosis that causes symptoms such as wheezing and fatigue that dramatically reduce the quality of life of the person with the disease.
Typically, the advanced stage of COPD is characterized by a fluctuating pattern and recurrent hospitalizations, and by a vicious circle in which dyspnoea increases and exercise tolerance reduces, which in turn causes depression and associated social isolation, low quality of life and increased risk of death.
Muscle dysfunction in these patients contributes together with ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age\> 50 years
- • clinical definition of COPD according to GOLD guidelines (10) with FEV1 / FVC G 70% and FEV1 \<50% of the above
- • PaO2 in air-ambient lower than 60 mmHg evaluated through arterial blood gas analysis
- • oxygen therapy prescription for more than 18 hours/ day for at least one month
- • clinical stable condition
- Exclusion Criteria:
- • presence of pulmonary diseases other than COPD
- • respiratory tract infections in the last 4 weeks
- • termination
About Istituti Clinici Scientifici Maugeri Spa
Istituti Clinici Scientifici Maugeri S.p.A. is a prestigious Italian healthcare organization dedicated to advancing medical research and clinical practice. With a strong focus on patient-centered care, the institution integrates innovative clinical trials into its comprehensive services, fostering collaboration between researchers and healthcare professionals. Known for its commitment to high-quality standards and ethical practices, Istituti Clinici Scientifici Maugeri S.p.A. plays a pivotal role in the development of new therapies and treatment modalities, contributing significantly to the global medical community and enhancing patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lumezzane, Brescia, Italy
Patients applied
Trial Officials
Mara Paneroni, MSc, PT
Principal Investigator
Istituti Clinici Scientifici Maugeri
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials